(Q36706601)

15 August 2017

Microcrystalline hydroxyapatite compound in prevention of bone loss in corticosteroid-treated patients with chronic active hepatitis (English)

1 reference

15 August 2017

Stellon A

1

1 reference

15 August 2017

Davies A

series ordinal

2

1 reference

15 August 2017

Webb A

series ordinal

3

1 reference

15 August 2017

Williams R

series ordinal

4

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 September 1985

1 reference

Postgraduate Medical Journal

15 August 2017

1 reference

15 August 2017

61

1 reference

15 August 2017

719

1 reference

15 August 2017

791-796

1 reference

Calcium metabolism in bone disease: effects of treatment with microcrystalline calcium hydroxyapatite compound and dihydrotachysterol.

15 August 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2418401

The Bone Mineral Content in the Forearm of Women with Colles' Fracture

5 September 2018

1 reference

12 December 2020

The relative merits of various techniques for measuring radiocalcium absorption

1 reference

12 December 2020

Clinical trial of microcrystalline hydroxyapatite compound ('Ossopan') in the prevention of osteoporosis due to corticosteroid therapy

1 reference

12 December 2020

Radiological patterns of cortical bone modelling in women with chronic liver disease

1 reference

12 December 2020

Vitamin D, hydroxyapatite, and calcium gluconate in treatment of cortical bone thinning in postmenopausal women with primary biliary cirrhosis

1 reference

12 December 2020

Histomorphometric analysis of bone biopsies from the iliac crest of normal British subjects

1 reference

12 December 2020

Treatment of osteoporosis with fluoride, calcium, and vitamin D

1 reference

12 December 2020

Identifiers

DOI

10.1136/PGMJ.61.719.791

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

2997764

1 reference